Jaguar Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Jaguar Health, Inc. (JAGX) on May 18, 2020, covering events occurring on May 15, 2020. The filing reports the results of the Company's 2020 Annual Meeting of Stockholders and references the issuance of a press release regarding First Quarter 2020 financial results.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the referenced press release (Exhibit 99.1) but are not detailed in the body of this Form 8-K.
Material Changes and Corporate Actions
The primary material event reported is the conclusion of the 2020 Annual Meeting of Stockholders, where four proposals were submitted and approved:
- Director Election: John Micek III was elected as a Class II director for a three-year term.
- Stock Plan Amendment: Stockholders approved an amendment to the 2014 Stock Plan to increase the annual replenishment of the share pool to 5% of the total number of shares outstanding as of December 31 of the preceding calendar year.
- Share Issuance: Approval was granted to issue shares of Common Stock to Oasis Capital, LLC for purposes of Nasdaq Rule 5635(d).
- Auditor Ratification: Stockholders ratified the appointment of Mayer Hoffman McCann P.C. as the independent registered public accounting firm for the fiscal year ended December 31, 2020.
Guidance, Outlook, and Risks
The filing does not contain specific management commentary, forward-looking guidance, or a discussion of risks and contingencies within the text provided. The document notes that the information in Item 2.02 and the attached exhibits shall not be deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Review Exhibit 99.1 for specific Q1 2020 financial results, including revenue and cash position.
- Verify the impact of the 5% annual stock plan replenishment on future dilution.
- Confirm the terms and pricing of the share issuance to Oasis Capital, LLC referenced in Proposal 3.
- Check the proxy statement for detailed voting breakdowns and any dissenting opinions regarding the proposals.